154 related articles for article (PubMed ID: 187943)
1. NIDA's naltrexone research program.
Julius D
NIDA Res Monogr; 1976 Sep; (9):5-11. PubMed ID: 187943
[No Abstract] [Full Text] [Related]
2. Evolution of the National Academy of Sciences study of naltrexone.
Kaim SC
NIDA Res Monogr; 1976 Sep; (9):37-44. PubMed ID: 794719
[No Abstract] [Full Text] [Related]
3. Narcotic antagonists: naltrexone progress report: introduction.
Renault PF
NIDA Res Monogr; 1976 Sep; (9):1-3. PubMed ID: 794713
[No Abstract] [Full Text] [Related]
4. Methadone maintenance and narcotic blocking drugs. Appendix.
Wikler A
Int J Addict; 1977 Oct; 12(7):869-81. PubMed ID: 338517
[TBL] [Abstract][Full Text] [Related]
5. The clinical usefulness of narcotic antagonists: implications of behavioral research.
Meyer RE; Mirin SM; Altman JL
Am J Drug Alcohol Abuse; 1975; 2(3-4):417-32. PubMed ID: 179316
[No Abstract] [Full Text] [Related]
6. Factors influencing success in an antagonistic treatment program.
Parwatikar S; Crawford J; Nelkupa JV; De Gracia C
NIDA Res Monogr; 1976 Sep; (9):77-81. PubMed ID: 794725
[No Abstract] [Full Text] [Related]
7. Methadone maintenance and narcotic blocking drugs.
Wikler A
Int J Addict; 1977 Oct; 12(7):851-6. PubMed ID: 201577
[TBL] [Abstract][Full Text] [Related]
8. Prospects, problems, side effects, and safety of narcotic antagonists.
Resnick RB
Int J Addict; 1977 Oct; 12(7):863-7. PubMed ID: 591144
[TBL] [Abstract][Full Text] [Related]
9. Patient response to naltrexone: issues of acceptance, treatment effects, and frequency of administration.
Curran S; Savage C
NIDA Res Monogr; 1976 Sep; (9):67-9. PubMed ID: 794722
[No Abstract] [Full Text] [Related]
10. A behavioral paradigm for the evaluation of narcotic antagonists.
Meyer RE; Mirin SM; Altman JL; McNamee HB
Arch Gen Psychiatry; 1976 Mar; 33(3):371-7. PubMed ID: 944026
[TBL] [Abstract][Full Text] [Related]
11. Narcotic antagonists: naltrexone progress report: foreword.
Jaffe J
NIDA Res Monogr; 1976 Sep; (9):v-vii. PubMed ID: 1088898
[No Abstract] [Full Text] [Related]
12. Clinical evaluation of naltrexone treatment of opiate-dependent individuals. Report of the National Research Council Committee on Clinical Evaluation of Narcotic Antagonists.
Arch Gen Psychiatry; 1978 Mar; 35(3):335-40. PubMed ID: 365122
[TBL] [Abstract][Full Text] [Related]
13. A history of the development of narcotic antagonists for the treatment of narcotic addiction.
Martin WR
NIDA Res Monogr; 1978; (19):296-300. PubMed ID: 218106
[No Abstract] [Full Text] [Related]
14. Short-term effects of naltrexone in 155 heroin ex-addicts.
Volavka J; Resnick RB; Kestenbaum RS; Freedman AM
Biol Psychiatry; 1976 Dec; 11(6):679-85. PubMed ID: 999987
[TBL] [Abstract][Full Text] [Related]
15. Research and development of naltrexone: a new narcotic antagonist.
Julius DA
Am J Psychiatry; 1979 Jun; 136(6):782-6. PubMed ID: 220890
[TBL] [Abstract][Full Text] [Related]
16. Analysis and modification of opiate reinforcement.
Meyer RE; McNamee HB; Mirin SM; Altman JL
Int J Addict; 1976; 11(3):467-84. PubMed ID: 184053
[TBL] [Abstract][Full Text] [Related]
17. Naltrexone in methadone maintenance patients electing to become "drug free".
Haas N; Ling W; Holmes E; Blakis M; Litaker M
NIDA Res Monogr; 1976 Sep; (9):70-3. PubMed ID: 794723
[No Abstract] [Full Text] [Related]
18. Experiences with Naltrexone in Buffalo.
Taintor Z; Landsberg R; Wicks N
Am J Drug Alcohol Abuse; 1975; 2(3-4):391-401. PubMed ID: 775969
[No Abstract] [Full Text] [Related]
19. NIDA's Medication Development Program--1989.
Schuster CR; Snyder M
NIDA Res Monogr; 1989; 95():64-73. PubMed ID: 2641056
[No Abstract] [Full Text] [Related]
20. Naltrexone in the management of heroin addiction: critique of the rationale.
Goldstein A
NIDA Res Monogr; 1976 Sep; (9):158-61. PubMed ID: 187941
[No Abstract] [Full Text] [Related]
[Next] [New Search]
